Core Insights - The U.S. markets are experiencing volatility due to shifting AI expectations, geopolitical tensions, inflation concerns, and the Federal Reserve's stance, yet a resilient economy and solid corporate earnings are preventing a complete risk-off sentiment [1] Group 1: Broker Recommendations - Retail investors are advised to consider broker recommendations to identify stocks for solid returns, with Crocs, National Energy Services Reunited Corp., and Koninklijke Philips N.V. highlighted as potential investments [2] - Brokers form informed views through management meetings, public disclosures, and earnings calls, providing a broader sector perspective that helps contextualize a company's fundamentals [3] Group 2: Stock Upgrades - Broker upgrades are often based on new information such as revised guidance or updated assumptions, which can signal potential inflection points before consensus expectations adjust [4] - An upgrade is one input in a broader investment case that should also consider business quality, valuation, industry structure, and individual investor factors [5] Group 3: Stock Screening Strategy - A screening strategy identifies potential winners by selecting stocks with broker rating upgrades of 1% or more over the past four weeks, trading above $5, and having an average 20-day volume greater than 100,000 [6] - Stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) have a proven record of success, especially when combined with a VGM Score of A or B [7] Group 4: Featured Stocks - Crocs, Inc. (CROX) is a leading footwear brand with a projected 7% earnings growth for 2026 and a 6.7% upward revision in broker ratings [8] - National Energy Services Reunited Corp. (NESR) is expected to see a 93.9% increase in 2026 earnings, with a 12.5% broker rating increase [10] - Koninklijke Philips N.V. (PHG) is projected to have a 6.3% earnings growth for 2026 and a 7.7% upward revision in broker ratings, currently holding a Zacks Rank of 1 [11]

Core Insights - Royal Philips published its Annual Report 2025, which will be discussed at the Annual General Meeting of Shareholders on May 8, 2026 [1] - The report has been filed with the Netherlands Authority for the Financial Markets in European Single Electronic Format and is expected to be filed with the U.S. Securities and Exchange Commission [2] - The Annual Report 2025 is accessible to shareholders and interested parties online, with printed copies available upon request [3] Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation [4] - The company specializes in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and personal health solutions, employing approximately 64,800 people and generating sales of EUR 18 billion in 2025 [5]

#NVIDIAhealthcare #medicalimaging Join Roland Rott, President and CEO of imaging at GE HealthCare, and Parry Bhatia, Chief AI Officer, to explore how GE HealthCare is transforming diagnostic imaging with cutting-edge AI technologies. Learn how AI-driven imaging is reshaping modern medicine, offering personalized insights and advancing health outcomes worldwide. Follow us: X: https://nvda.ws/4hi2sxB LinkedIn: https://nvda.ws/4eSlE3B Subscribe to the NVIDIA AI Healthcare Newsletter: https://nvda.ws/4eS1F54 ...

Group 1: Goodman Group (GMG) - Goodman Group's share price has decreased approximately 5.9% since the beginning of 2025, making it the largest ASX-listed property group in 2025 with operations across multiple continents including Australia, New Zealand, the UK, Japan, the US, and Brazil [1] - The company specializes in warehouses, large-scale logistics facilities, and business and office parks, aiming to build long-term relationships with customers and deliver high-quality assets [2] - The current dividend yield for Goodman Group shares is around 0.88%, which is lower than its 5-year average of 1.28%, indicating a potential decline in dividends or an increase in share price [6] Group 2: Sonic Healthcare (SHL) - Sonic Healthcare, listed in April 1987, is one of the largest pathology businesses globally, with operations in Australia, New Zealand, Europe, and North America, offering services such as laboratory medicine, pathology, diagnostic imaging, and corporate medical services [3][4] - The current price-sales ratio for Sonic Healthcare shares is 1.19x, which is below its 5-year long-term average of 1.94x, suggesting that SHL shares may be undervalued [7] - Sonic Healthcare focuses on acting in the best interests of doctors and patients, striving for medical excellence and being a desirable workplace [4]